Published by Josh White on 24th March 2023
(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma announced the publication of landmark clinical data for 'XF-73' on Friday, in the US-based peer-reviewed journal Infection Control & Hospital Epidemiology.
URL: http://www.digitallook.com/dl/news/story/33392393/...